HRT Financial’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $146K | Buy |
+72,222
| New | +$146K | ﹤0.01% | 1835 |
|
2024
Q2 | – | Sell |
-76,695
| Closed | -$1.06M | – | 2447 |
|
2024
Q1 | $1.06M | Buy |
76,695
+64,976
| +554% | +$901K | 0.01% | 821 |
|
2023
Q4 | $71K | Buy |
11,719
+10,110
| +628% | +$61.3K | ﹤0.01% | 1760 |
|
2023
Q3 | $7K | Sell |
1,609
-22,151
| -93% | -$96.4K | ﹤0.01% | 1930 |
|
2023
Q2 | $127K | Buy |
+23,760
| New | +$127K | ﹤0.01% | 1746 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 3142 |
|
2022
Q1 | – | Sell |
-2,525
| Closed | -$151K | – | 3141 |
|
2021
Q4 | $151K | Sell |
2,525
-1,938
| -43% | -$116K | ﹤0.01% | 2356 |
|
2021
Q3 | $383K | Sell |
4,463
-1,811
| -29% | -$155K | ﹤0.01% | 2021 |
|
2021
Q2 | $697K | Buy |
+6,274
| New | +$697K | 0.01% | 1423 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 2677 |
|
2020
Q1 | – | Sell |
-8,937
| Closed | -$353K | – | 916 |
|
2019
Q4 | $353K | Buy |
+8,937
| New | +$353K | 0.02% | 632 |
|
2015
Q3 | – | Sell |
-1,302
| Closed | -$127K | – | 130 |
|
2015
Q2 | $127K | Buy |
+1,302
| New | +$127K | 0.06% | 147 |
|